Nuo Therapeutics, Inc. (AURX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$5.40M2011: -$3.51M2012: -$12.89M2013: -$18.10M2014: -$23.39M2015: -$41.32M2017: -$15.53M2018: -$1.50M2019: -$969.2K2020: -$378.1K2021: -$90.7K2022: -$3.32M2023: -$3.17M2024: -$2.46M2025: -$2.52M-$2.52M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$2.52M-2.4%
2024-$2.46M+22.4%
2023-$3.17M+4.6%
2022-$3.32M-3562.3%
2021-$90.7K+76.0%
2020-$378.1K+61.0%
2019-$969.2K+35.6%
2018-$1.50M+90.3%
2017-$15.53M
2015-$41.32M-76.6%
2014-$23.39M-29.3%
2013-$18.10M-40.3%
2012-$12.89M-266.9%
2011-$3.51M+35.0%
2010-$5.40M